Truepill

Emerging#15 in Healthcare

Acquired by LetsGetChecked August 2024 for $525M; $322M total funding; $66.2M Series D August 2023; $1.6B valuation; 1M+ prescriptions processed

Digital Pharmacy Infrastructure
Visit Website
Updated April 2026

Company Overview

Truepill is a digital pharmacy infrastructure provider that enables healthcare companies, telehealth platforms, and retailers to offer pharmacy services through white-label fulfillment and technology solutions. The company serves digital health startups, health systems, retailers, and telemedicine providers who want to integrate prescription fulfillment into their offerings without building pharmacy infrastructure. Truepill operates a nationwide network of licensed pharmacies and provides end-to-end pharmacy services including prescription processing, medication dispensing, and direct-to-patient delivery.

Revenue
$525M
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Truepill is an emerging player bringing innovative solutions to the Healthcare market.

Growth Stage

Truepill has achieved $525M in revenue, demonstrating strong product-market fit.

Frequently Asked Questions

Not So Random Others

Yoneda Labs

Healthcare
HealthtechB2bNorth America

Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit

Decoda Health

Healthcare
HealthtechAi PoweredAutomationNorth America

Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap

Fortuna Health

Healthcare
HealthtechB2bAi PoweredAutomationNorth America

Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

AbbVie

Healthcare
AnalyticsB2bEnterpriseGlobalHealthtechPublic

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp

Compare Truepill with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Truepill

Claim This Profile

Are you from Truepill? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Truepill Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Truepill vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →